Epidemiology of subsequent bloodstream infections in the ICU

Niccolò Buetti; Elia Lo Priore; Rami Sommerstein; Andrew Atkinson; Andreas Kronenberg; Jonas Marschall; Swiss Centre for Antibiotic resistance (ANRESIS)

doi:10.1186/s13054-018-2148-0

Epidemiology of subsequent bloodstream infections in the ICU

Crit Care. 2018 Oct 11;22(1):259. doi: 10.1186/s13054-018-2148-0.

Authors

Niccolò Buetti¹, Elia Lo Priore², Rami Sommerstein², Andrew Atkinson², Andreas Kronenberg³, Jonas Marschall²; Swiss Centre for Antibiotic resistance (ANRESIS)

Collaborators

Swiss Centre for Antibiotic resistance (ANRESIS):
A Burnens, A Cherkaoui, V Gaia, O Dubuis, A Egli, D Koch, A Kronenberg, S Luyet, P Nordmann, V Perreten, J-C Piffaretti, G Prod'hom, J Schrenzel, S L Leib, A F Widmer, G Zanetti, R Zbinden

Affiliations

¹ Department of Infectious Diseases, University Hospital Bern, Bern, Switzerland. niccolo.buetti@gmail.com.
² Department of Infectious Diseases, University Hospital Bern, Bern, Switzerland.
³ Institute for Infectious Diseases, University of Bern, Bern, Switzerland.

Abstract

Subsequent bloodstream infections (sBSI) occur with a delay after removal of the intravascular catheter (IVC) whose tip revealed microbial growth. Here we describe the epidemiology of sBSI in the intensive care setting. Serratia marcescens, Staphylococcus aureus, Pseudomonas aeruginosa, and yeast were the pathogens most frequently associated with sBSI. In contrast, Enterococci were rarely found in sBSI.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Bacteremia / epidemiology*
Catheter-Related Infections / complications*
Catheter-Related Infections / epidemiology
Humans
Intensive Care Units / organization & administration
Intensive Care Units / statistics & numerical data
Pseudomonas aeruginosa / pathogenicity
Serratia marcescens / pathogenicity
Staphylococcus aureus / pathogenicity
Switzerland / epidemiology